FMW Media's New to The Street announces its corporate TV
appearances on Newsmax and the FOX Business Network.
New to The Street airs
Episode 518 on Newsmax on Saturday, October 07, 2023, at 3:30 PM
ET, and Episode 519 on the FOX Business Network on Monday, October
9, 2023, at 10:30 PM PT, featuring the following five corporate
interviews:
1). Biopharmaceutical– Vincerx Pharma,
Inc.'s (NASDAQ: VINC) ($VINC) interview with Alex
Seelenberger, Chief Financial Officer.
2). Pet Health – PetVivo Holdings, Inc.'s (NASDAQ:
PETV) (NASDAQ: PETVW) ($PETV) interviews with John Lai, CEO &
President, and Judd Spodek, Owner/Trainer, Sit Happens, Inc.
3). Tax-Free Retirement – Kohler Tax Associates'
interview with Mark Kohler, M.PR.A., CPA, JD, and Founder.
4) Artist – Hope Tian Oil Painting's interview
with Hope Tian, Artist/Owner.
5). "Sekur Privacy & Sekur Security
Segment – The Weekly
Hack" interview with internet privacy expert Mr. Alain
Ghiai, CEO, Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR)
(FRA: GDT0) ($SWISF) (Sekur®).
From the Nasdaq MarketSite Studio, New to The
Street airs TV Host Jane King's interview with Alex Seelenberger,
Chief Financial Officer of Vincerx Pharma, Inc. (NASDAQ:
VINC) ($VINC). As a clinical-stage biopharmaceutical Company,
Vincerx leverages its oncology expertise, focusing on developing
new and advanced novel cancer drugs. Chemotherapies and radiation
treatments are incredibly harmful to patients trying to beat
cancer. These historical treatments come with many harmful toxic
side effects where patients weigh the options over quality of life
or life itself. Alex informs viewers about an upcoming class of
drug treatments called antibody-drug conjugates (ADCs). These drugs
target cancer, attaching and killing those cells. Unfortunately,
FDA-approved ADCs in the marketplace still have risks, where
toxicity is still occurring, killing and destroying good
cells/tissues. Vincerx's world-class management and scientific
teams with decades of experience, numerous drug approvals, and
regulatory expertise are developing next-generation ADCs that
aggressively attack targeted cancer cells but dramatically diminish
toxicity and healthy cell/tissue destructions. The Company's drug
pipeline includes ADCs and small molecule drug conjugate (SMDC),
all under development to combat different cancers with expected
positive life-changing results for cancer patients. VIP236, an SMDC
under development for treating advanced/metastatic solid tumors,
has shown great lab results, and the developmental drug is in FDA
Phase I clinical trial. Management expects data from the clinical
to be forthcoming in 2024. Management recently entered an FDA Phase
I clinical on VIP943, an ADC for treating certain types of
leukemia, and published results on the study are expected to come
sometime in 2024. The Company is developing VIP924, a treatment for
multiple malignancies, and VIP512, a combination drug agent.
Vincerx Pharma is aggressively addressing the unmet medical needs
of patients with cancer through novel and innovative drug
treatments. The on-screen QR code is available during the show;
download or visit Vincerx Pharma, Inc. - https://vincerx.com/.
The interview will air on Newsmax, episode 518, on October 7, 2023,
at 3:30 PM ET, and the FOX Business Network, episode 519, on
October 9, at 10:30 PM PT.
John Lai, PetVivo Holdings, Inc.'s (NASDAQ:
PETV) (NASDAQ: PETVW) ($PETV) CEO/President, and Judd Spodek,
Owner/Trainer, Sit Happens, Inc. talk on location with New to The
Street's TV Host Jane King. PETV's patented product, Spryng with
OsteoCushion Technology, gives veterinarians a tool to help pet
owners manage their pets' osteoarthritis and joint-related
ailments. John informs viewers that in October 2022, the Spryng
product was in fifty (50) clinics in a handful of states, but in
July 2023, the product is available in five hundred (500) clinics
in 49 states. The equine marketplace is the most extensive consumer
of the product, but K-9 and feline treatment use is rising. The
Company has several studies pending. Once data is available, the
Company's sales/marketing team will have more data to approach more
veterinarians. The FDA designated the animal product as a device,
and it has proven efficacy and safety. Judd Spodek, Owner/Trainer
of Sit Happens, Inc., a dog training company in New York City/Long
-Island, shares his experience with Spryng on his elderly
15-year-old dog, Joey. After consulting with the dog's veterinarian
and exhausting all other ineffective options, the vet told Judd
about PETV's Spryng. They injected his dog, and within a few days,
the results were terrific, with the dog walking again with
apparently no pain or discomfort. Judd is telling all his clients
and others about PETV's Spryng with OsteoCushion Technology,
especially with owners whose pets are showing lameness and other
joint problems. Viewers can learn more about PetVivo Cares, a
non-profit organization that helps pets who are suffering from
pain and lameness in their joints. John says to follow the
Company’s progress on its social media sites and to receive news
and updates from the website, https://petvivo.com/. The on-screen
QR code is available during the show; download or visit PetVivo
Holdings, Inc. - https://petvivo.com/ & Spryng with
OsteoCushion Technology - https://www.sprynghealth.com/. The
interview will air on Newsmax, episode 518, on October 7, 2023, at
3:30 PM ET, and the FOX Business Network, episode 519, on October
9, at 10:30 PM PT.
TV Host Jane King from New to The Street and
Co-Host David T. Fagan, President of Top Talent Agency from
the Nasdaq MarketSite Studio, talk with Mark Kohler,
M.PR.A., CPA, JD, and Founder of Kohler Tax Associates. The Biden
Administration is considering lowering the maximum amounts one can
contribute to Roth IRA accounts. Regardless of the pending changes,
Mark explains the importance and the numerous benefits of funding a
Roth IRA. With tax-free contributions and family surviving rights,
a Roth IRA is a great way to store and grow wealth, especially for
the self-employed. Many tax advisors, including Mark, believe that
the US Social Security system will continue to have financial
shortcomings, and people need to look for financial security
solutions beyond social security. As a corporate CFO/Director at
Directed IRA, Mark explains more about self-direct Roth IRAs and
how anyone can easily set one up at Directed IRA. Self-direct Roth
IRA account holders with Direct IRA can invest in anything they
choose. Mark is an Author and YouTube Media and PodCast Host
offering tax advice to millions. The on-screen QR code is available
during the shows; download or visit Kohler Tax Associates -
https://markjkohler.com/. The interview will air on Newsmax,
episode 518, on October 7, 2023, at 3:30 PM ET, and the FOX
Business Network, episode 519, on October 9, at 10:30 PM PT.
New to The Street's TV Host Jane King, from the
Nasdaq MarketSite Studio, interviews Hope Tian, Artist/Owner of
Hope Tian Oil Painting. Hope was born and raised in Beijing, China,
and in the late 1990s, she moved to the US to pursue her graduate
degree in New York State. In 2011, Hope painted a portrait for her
son as his birthday gift; she realized her talent and pursued her
art career. As self-taught and working with oil, Tian creates
beautiful art depicting portraits, landscapes, seascapes, and still
life, anything that inspires her. Tian explains that she visualizes
each oil canvas painting before beginning each artwork.
Inspirations can come from the Master artists or the simplest of
events in her life, but LOVE provides her with the most inspiration
for her creativity. Art taught Hope that anything is possible, and
that pursuing her passion becomes a fulfilling career. She is
grateful for her family, friends, other artists, and the art
gallery communities, all providing support and influential
inspiration for her oils. Currently living in Massachusetts,
artwork done by Hope Tian is available for sale, or you can
commission her talent for your unique and personal piece of art.
The on-screen QR code is available during the show; download or
visit Hope Tian Oil Painting - https://www.hopetianart.com/. The
interview will air on Newsmax, episode 518, on October 7, 2023, at
3:30 PM ET, and the FOX Business Network, episode 519, on October
9, at 10:30 PM PT.
Alain Ghiai, internationally acclaimed internet
privacy expert, and the CEO of Sekur Private Data,
Ltd. (OTCQX: SWISF) (CSE:
SKUR) (FRA: GDT0) and TV Host/Multi-media Journalist Ana Berry on
New to The Street's "Sekur Privacy & Sekur Security
Segment – The Weekly Hack" talk about another
cybersecurity topic – AI chat products. "The Hackers News" recently
reported on Microsoft Bing's artificial intelligence (AI) chatbot
directing end-users to malware sites. End-users unknowingly
download malware from the site onto their devices. Text messages,
emails, fake ads, and other cyber threats exist, where hackers
constantly try to steal data using malware and
ransomware-downloaded codes. Alain informs viewers that Big Tech
platforms often track website use, and hackers have that data.
Hackers cleverly create emails and texts containing malware links
that focus on points-of-interest matters developed from obtained
web traffic data. A VPN (Virtual Private Network) allows one to
cruise the internet with privacy. Unfortunately, some VPN services
use 3rd party Big Tech platforms that are known to sell traffic
data to other entities, limiting privacy concerns. Sekur.com's
SekurVPN is a superior product that never tracks data and never
sells data to 3rd parties. Priced reasonably, SekurVPN has its
end-users always appearing in Switzerland no matter where they are
on the net globally. It is straightforward to install on Mac,
Windows, iOS, and Android devices. SekurVPN, SekurMail,
SekurMessenger, and other Sekur service offerings all come with
superior military encryption technology, and all products operate
on Sekur's 100% owned servers located in Switzerland. Alain is
still offering PROMO CODE: PRIVACY, a 15% savings
monthly and yearly on SekurVPN and other service plans; the
discount is good for five years. Remember Sekur Private Data, Ltd.
operates its internet platforms and security businesses under the
country of Switzerland's very tough privacy laws. It never data
mines, sells data, asks for a phone number, uses 3rd party
platforms, and tracks web traffic. The on-screen QR code is
available during the shows to download more info or visit Sekur
Private Data, Ltd. –https://sekurprivatedata.com/ivatedata.com/,
http:/sekur.com/ and https://www.sekurvpn.com/. "What is
your privacy worth?" The interview will air on Newsmax,
episode 518, on October 7, 2023, at 3:30 PM ET, and the FOX
Business Network, episode 519, on October 9, at 10:30 PM PT.
About Vincerx Pharma,
Inc.
(NASDAQ: VINC)
($VINC):
Vincerx Pharma, Inc.
(NASDAQ: VINC) ($VINC) is a
clinical-stage biopharmaceutical company committed to developing
differentiated and novel therapies to address the unmet medical
needs of patients with cancer. Vincerx has assembled a seasoned
management team with a proven track record of successful oncology
drug development, approvals, and value creation. The Company's
diverse pipeline consists of the next-generation antibody
conjugate, VIP943, in Phase 1; small molecule drug-conjugate,
VIP236, in Phase 1; preclinical antibody-drug conjugate, VIP924;
CDK9 inhibitor, enitociclib, currently in an NIH-sponsored
Phase 1; and its next-generation modular bioconjugation platform.
Vincerx is based in Palo Alto, California, and has a research
facility in Monheim, Germany - www.vincerx.com.
About PetVivo Holdings,
Inc. (NASDAQ: PETV) (NASDAQ: PETVW)
($PETV):
PetVivo Holdings Inc. (NASDAQ: PETV) (NASDAQ:
PETVW) ($PETV) is an emerging biomedical device company currently
focused on the manufacturing, commercialization, and licensing of
innovative medical devices and therapeutics for companion animals.
The Company's strategy is to leverage human therapies for treating
companion animals in a capital and time-efficient way. A vital
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for treating animals
and people. A portfolio of nineteen patents protects the Company's
biomaterials, products, production processes, and use methods. The
Company's lead product, Spryng™ with
OsteoCushion™ technology, a veterinarian-administered,
intraarticular injection for managing lameness and other
joint-related afflictions, including osteoarthritis, in dogs and
horses, is currently available for commercial sale -
https://petvivo.com/ and https://www.sprynghealth.com/.
About Kohler Tax
Associates / Mark Kohler,
M.PR.A., C.P.A., J.D:
Kohler Tax Associates' mission is to help business
owners and investors find a Certified Tax Advisor that implements
'street smart tax strategies' and helps their clients build wealth,
protect their assets, and plan their estate and legacy. Kohler Tax
Associates' Founder, Mark J. Kohler, is a CPA, Attorney, co-host of
the PodCasts "The Main Street Business
Podcast" and the author of "The Business Owner's
Guide to Financial Freedom- What Wall Street Isn't Telling
You" as well as several other well-known books. He is also the
CFO of Directed IRA Trust Company and a senior partner at the
law firm KKOS Lawyers. By contacting Kohler Tax Associates,
you will find a tax advisor trained to help you save taxes and
better live Your American Dream - https://markjkohler.com/
About Hope Tian Oil
Painting: Hope Tian Oil Painting's Artist/Owner, Hope
Tian, finds great excitement and creativity in exploring varied
subjects and eclectic oil painting styles. Her artwork ranges
from impressionistic or post-impressionistic to expressionistic or
fauvist to truly representational to abstract. Hope's
paintings are heavily influenced by her keen interest in and
ongoing study of master painters. Standing before Hope Tian's
original oil painting, there is a deep emotional expression,
creatively textured layering, vividly vibrant colors, and lively
free brush strokes ranging from the lightest touch to heavy, thick
paint, all resulting in a unique artistic experience -
https://www.hopetianart.com/.
About Sekur Private Data
Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0)
($SWISF):
Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE:
SKUR) (FRA: GDT0) ($SWISF) is a cybersecurity and internet privacy
provider of Swiss-hosted solutions for secure communications and
secure data management. The Company distributes a suite of secure
cloud-based storage, disaster recovery, document management,
encrypted emails, and secure communication tools. It sells its
products through its websites, www.sekur.com, approved
distributors, and telecommunication companies worldwide. Sekur
Private Data, Ltd. serves consumers, businesses, and governments
worldwide -
https://www.sekurprivatedata.com and https://www.sekur.com;
Twitter: @sekurprivate.
About New to The
Street:
New to The Street is an FMW Media production that
operates one of the longest-running US and International sponsored
and syndicated Nielsen-rated programming television brands, "New to
The Street." Since 2009, New to The Street has run biographical
interview segment shows across major U.S. television networks. The
Nielsen Rated and sponsored broadcasts programming platform reaches
millions of homes in the US and international markets. FMW's New to
The Street / Newsmax televised broadcasting platform airs its
syndication on Saturdays at 3:30 – 4:00 PM ET. The show also
appears on Bloomberg and the FOX Business Network as sponsored
programming. FMW is also one of the nation's largest buyers of
linear television, long and short-form paid programming -
https://www.newsmaxtv.com/Shows/New-to-the-Street,
https://www.newtothestreet.com/ &
https://www.youtube.com/watch?v=4-G2--mRQUw&t=14s.
Forward-Looking Statements Disclaimer
US/Canada:
This press release contains forward-looking
statements within Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934. In
some cases, you can identify forward-looking statements by the
following words: "anticipate," "believe," "continue," "could,"
"estimate," "expect," "intend," "may," "ongoing," "plan,"
"potential," "predict," "project," "should," "will," "would," or
the negative of these terms or other comparable terminology.
However, not all forward-looking statements contain these words.
Forward-looking statements do not guarantee future performance or
results and will not necessarily be accurate indications of when
such performance or results are achieved. This press release should
be considered in all filings of the Companies contained in the
Edgar Archives of the Securities and Exchange Commission at
www.sec.gov.
This press release contains forward-looking
information within the meaning of applicable Canadian securities
laws. Forward-looking information is often, but not always,
identified by the use of words such as "seek," "anticipate",
"believe," "plan," "estimate," "expect," "likely" and "intend" and
statements that an event or result "may," "will," "should," "could"
or "might" occur or be achieved and other similar expressions.
These statements reflect management's current beliefs and are based
on information currently available to management as of the date
hereof. Forward-looking information in this press release includes,
without limiting the foregoing, expectations regarding agents that
join Real. Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
CONTACT:
FMW Media Contact: Monica Brennan
monica@NewtoTheStreet.com 1-917-330-2564
"New to The Street" Business Development Office
1-516-696-5900 Support@NewToTheStreet.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/8718870b-131d-44c8-adf6-e3188c957472
A video accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/ec596a04-a37f-4bfd-a368-f0f79b20f7eb
Grafico Azioni Vincerx (NASDAQ:VINC)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Vincerx (NASDAQ:VINC)
Storico
Da Nov 2023 a Nov 2024
